SARILUMAB AS MONOTHERAPY OR IN COMBINATION WITH CONVENTIONAL SYNTHETIC DMARDS IN PATIENTS WITH RHEUMATOID ARTHRITIS: 12-WEEK TREATMENT RESULTS FROM A MULTICENTER, OPEN-LABEL, PROSPECTIVE, SINGLE-ARM OBSERVATIONAL STUDY

被引:0
|
作者
Kivitz, A. [1 ]
Gottenberg, J. E. [2 ]
Bergman, M. [3 ]
Iglesias-Rodriguez, M. [4 ]
St John, G. [5 ]
Qiu, C. [6 ]
Van Hoogstraten, H. [6 ]
Bessette, L. [7 ]
机构
[1] Altoona Ctr Clin Res, Duncansville, PA USA
[2] Hop Univ Strasbourg, Strasbourg, France
[3] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA
[4] Sanofi Genzyme, Cambridge, MA USA
[5] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[6] Sanofi, Bridgewater, NJ USA
[7] Laval Univ, Quebec City, PQ, Canada
关键词
D O I
10.1136/annrheumdis-2020-eular.1972
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB0301
引用
收藏
页码:1446 / 1446
页数:1
相关论文
共 50 条
  • [21] Long-term safety of nebivolol and valsartan combination therapy in patients with hypertension: an open-label, single-arm, multicenter study
    Neutel, Joel M.
    Giles, Thomas D.
    Punzi, Henry
    Weiss, Robert J.
    Li, Huiling
    Finck, Amy
    JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2014, 8 (12) : 915 - 920
  • [22] EFFICACY AND SAFETY OF DIFFERENT SCHEMES OF ETORICOXIB ADMINISTRATION IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS - RESULTS OF A 12-WEEK, PROSPECTIVE, OPEN-LABEL STUDY
    Gaydukova, I.
    Rebrov, A.
    Nikitina, N.
    Nam, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 718 - 718
  • [23] Flexible dosing with paliperidone ER in the treatment of patients with acutely exacerbated schizophrenia: results from a single-arm, open-label study
    Schmauss, Max
    Jukic, Vlado
    Siracusano, Alberto
    Bidzan, Leszek
    Badescu, George M.
    Maciulis, Valentinas
    Lahaye, Marjolein
    Hoeben, Dagmar
    Tessier, Christophe
    Schreiner, Andreas
    CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (08) : 1395 - 1404
  • [24] Aripiprazole augmentation for treatment of patients with chronic or recurrent major depressive disorder: a 12-week prospective open-label multicentre study
    Pae, Chi-Un
    Jeon, Hong Jin
    Lee, Boung Chul
    Seo, Ho-Jun
    Kim, Shin Gyeom
    Park, E-Jin
    Kim, Won
    Kwak, Kyung-Phil
    Han, Changsu
    Cho, Seong-Jin
    Hahn, Sang-Woo
    Jon, Duk-In
    Choi, Jin-Hyuk
    Jun, Tae-Youn
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2013, 28 (06) : 322 - 329
  • [25] BLOOD PRESSURE CONTROL OF NIFEDIPINE GITS 60MG TREATMENT IN PREVIOUSLY UNCONTROLLED HYPERTENSIVE PATIENTS: A PROSPECTIVE, OPEN-LABEL, MULTICENTER, SINGLE-ARM, 8WEEK STUDY
    Liu, L.
    Zhang, Y.
    Lu, F.
    Zhao, Y.
    Wu, Y.
    Gao, P.
    Chen, S.
    Chen, L.
    Yang, T.
    Sun, Y.
    Yao, W.
    Ji, X.
    Mu, J.
    Li, S.
    JOURNAL OF HYPERTENSION, 2018, 36 : E152 - E152
  • [26] Efficacy and safety of sorafenib in combination with gemcitabine in patients with advanced hepatocellular carcinoma: A multicenter, open-label, single-arm phase II study
    Srimuninnimit, Vichien
    Sriuranpong, Virote
    Suwanvecho, Suthida
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 (03) : 255 - 260
  • [27] Safety and tolerability of cariprazine in the long-term treatment of schizophrenia: results from a 48-week, single-arm, open-label extension study
    Durgam, Suresh
    Greenberg, William M.
    Li, Dayong
    Lu, Kaifeng
    Laszlovszky, Istvan
    Nemeth, Gyorgy
    Migliore, Raffaele
    Volk, Stephen
    PSYCHOPHARMACOLOGY, 2017, 234 (02) : 199 - 209
  • [28] Safety and tolerability of cariprazine in the long-term treatment of schizophrenia: results from a 48-week, single-arm, open-label extension study
    Suresh Durgam
    William M. Greenberg
    Dayong Li
    Kaifeng Lu
    Istvan Laszlovszky
    Gyorgy Nemeth
    Raffaele Migliore
    Stephen Volk
    Psychopharmacology, 2017, 234 : 199 - 209
  • [29] Subcutaneous CERA for the Maintenance Treatment of Anemia in Pediatric Patients With CKD: A Phase 2, Open-Label, Single-Arm, Multicenter Study
    Warady, Bradley A.
    Reigner, Sylvie Meyer
    Tirodkar, Chitra
    Drozdz, Dorota
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2023, 81 (06) : 684 - +
  • [30] Evocalcet in patients with primary hyperparathyroidism: an open-label, single-arm, multicenter, 52-week, dose-titration phase III study
    Takeuchi, Yasuhiro
    Nishida, Yuichi
    Kondo, Yuichiro
    Imanishi, Yasuo
    Fukumoto, Seiji
    JOURNAL OF BONE AND MINERAL METABOLISM, 2020, 38 (05) : 687 - 694